Lexington, KY, April 16, 2015 (GLOBE NEWSWIRE)
Transposagen, a world leader in genome engineering technologies and services, announced the registration of its trademark OncoRat™ by the USPTO, for use with rat models for oncology in issued patent No. 8,722,964. OncoRat™ covers all genetically engineered rat models with oncology phenotypes, regardless of the method used to create the rat model (e.g. site-specific nucleases, homologous recombination, transposon insertion, etc.).